<DOC>
<DOCNO>
EP-0005733
</DOCNO>
<TEXT>
<DATE>
19791212
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/135 A61P-1/16 A61P-1/00 A61P-3/08 A61P-3/00 <main>A61K-31/135</main> A61P-3/10 
</IPC-CLASSIFICATIONS>
<TITLE>
pharmaceutical compositions for use in the treatment of diabetic nephropathy and method for preparing them.
</TITLE>
<APPLICANT>
thomae gmbh dr kde<sep>dr. karl thomae gmbh<sep>dr. karl thomae gmbhbirkendorferstrasse 65 d-88397 biberachde<sep>dr. karl thomae gmbh<sep>
</APPLICANT>
<INVENTOR>
clamp john richard prof dr <sep>hartog martin dr<sep>shelley julian henry dr<sep>clamp, john richard, prof. dr.<sep>hartog, martin, dr.<sep>shelley, julian henry, dr.<sep>clamp, john richard, prof. dr.victoria squarebristolgb<sep>hartog, martin, dr.frenchay lodge east beckspool roadfrenchay bristolgb<sep>shelley, julian henry, dr.speen holt west speen lanenewbury berkshiregb<sep>clamp, john richard, prof. dr. <sep>hartog, martin, dr.<sep>shelley, julian henry, dr.  <sep>clamp, john richard, prof. dr.victoria squarebristolgb<sep>hartog, martin, dr.frenchay lodge east beckspool roadfrenchay bristolgb<sep>shelley, julian henry, dr.speen holt west speen lanenewbury berkshiregb<sep>
</INVENTOR>
<ABSTRACT>
the present invention describes pharmaceutical compositions  for use in the treatment of diabetic nephropathy  containing from 15 to 30 mg of n-(2-amino-3,5-dibromobenzyl)-n-methyl-cyclohexylamine  and/or a physiologically  compatible acid addition salt thereof as active  ingredient, their method and their preparation.  
</ABSTRACT>
</TEXT>
</DOC>
